Virbac SA
SWB:V16
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Virbac SA
SWB:V16
|
FR |
|
T
|
Thaire Life Assurance PCL
SET:THREL
|
TH |
|
Maan Aluminium Ltd
BSE:532906
|
IN |
|
C
|
Compagnie de Saint Gobain SA
XBER:GOB
|
FR |
|
P
|
Polimex Mostostal SA
WSE:PXM
|
PL |
|
Cooper Companies Inc
F:CP60
|
US |
|
Molson Coors Beverage Co
F:NY70
|
US |
|
H2O Innovation Inc
XTSX:HEO
|
CA |
|
C
|
Chesapeake Energy Corp
XBER:CS1
|
US |
|
Evolution Mining Ltd
ASX:EVN
|
AU |
|
ITV PLC
LSE:ITV
|
UK |
|
Schibsted ASA
LSE:0MHM
|
NO |
|
Alsea SAB de CV
F:4FU
|
MX |
|
Beigene Ltd
OTC:BEIGF
|
KY |
|
C
|
Cleveland-Cliffs Inc
XBER:CVA
|
US |
|
G
|
G Enone Energy Co Ltd
KOSDAQ:270520
|
KR |
|
C
|
China Southern Airlines Co Ltd
HKEX:1055
|
CN |
|
Old Dominion Freight Line Inc
NASDAQ:ODFL
|
US |
Bankruptcy Probability
Virbac SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Virbac SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Virbac SA
PAR:VIRP
|
3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
554.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
227.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
249.2B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Virbac SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Virbac SA has total debt of 175.3m EUR. This includes both short-term (1.2m EUR) and long-term (174.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.
